The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trial.
Schiavina R, Droghetti M, Novara G, Bianchi L, Gaudiano C, Panebianco V, Borghesi M, Piazza P, Mineo Bianchi F, Guerra M, Corcioni B, Fiorentino M, Giunchi F, Verze P, Pultrone C, Golfieri R, Porreca A, Mirone V, Brunocilla E.
Schiavina R, et al. Among authors: pultrone c.
Urol Oncol. 2021 Jul;39(7):433.e1-433.e7. doi: 10.1016/j.urolonc.2020.10.018. Epub 2020 Nov 13.
Urol Oncol. 2021.
PMID: 33191117
Clinical Trial.